Navigation Links
Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0
Date:3/18/2009

IRVINE, Calif., March 18 /PRNewswire/ -- Relsys International today announced the release of the Argus Safety Suite 5.0, the new standard in global Drug Safety & Risk Management systems. The Argus Safety Suite 5.0 is a full stack release.

Argus Safety 5.0 features important productivity and usability enhancements to the most widely used adverse events management system in the world. It also features ongoing performance enhancements to the highly stable and efficient Argus database, ensuring that pharma companies can rapidly process and manage all of their reporting obligations.

Argus Perceptive 5.0 is a leading risk management system, pioneering the Structured Signal Management (SSM) approach. Argus Perceptive 5.0 enables powerful risk assessments with greater data accuracy, ensuring that medical reviewers get advanced notice of signals and potentially leading to earlier risk identification. While adhering to the Structured Signal Management approach, pharma companies ensure that their surveillance teams follow the signal and risk management process according to company-defined SOPs within an integrated environment.

Bruce Palsulich, Chief Innovation & Strategy Officer at Relsys, commented, "Increasing regulatory scrutiny and greater physician/consumer awareness have led directly to a record number of adverse events reported to regulators. In fact, in the first quarter of 2008, the FDA received a record number of adverse event reports, 82% of which originated from manufacturers. Pharma companies are struggling to meet this burden and are increasingly looking to commercial drug safety databases to help manage their regulatory requirements. I believe this is exactly why more than 1 out of every 3 of the Top 100 pharma have selected Argus Safety from Relsys to manage their pharmacovigilance obligations." Palsulich continued, "Furthermore, pharma is learning that signal detection tools by themselves do not solve their problems. Many companies now realize that Structured Signal Management provides a framework to transform large amounts of data into useful and actionable information. This is how Argus Perceptive adds true value to the science of signal detection."

Parties interested in learning more about the Argus Safety(TM) Suite 5.0 may visit the Relsys at the DIA EuroMeeting (booth #1240) in Berlin, Germany or may request a copy of the Structured Signal Management white paper via email at info@relsys.net.

About Relsys International

Relsys International provides the industry-leading Argus Safety Suite, a complete solution for pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve product safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients' corporate risk management strategies. Argus Safety(TM), the company's flagship product, is the world's best selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.


'/>"/>
SOURCE Relsys International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Relsys International Launches the Pharmacovigilance Integrated Services Offering and Significantly Expands Project Delivery Capabilities
2. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
3. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008
4. Irish-Owned Heritage Casket Company Strikes Multi-Million-Dollar Partnership Deal With Pennsylvanias Matthews International
5. AJWS Asks International Community to Demand Reinstatement of International Aid Groups Into Sudan
6. Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
7. Autism Speaks Celebrates Second Annual World Autism Awareness Day with an Array of International Events on April 2
8. Dr. James F. Pingpank to Present at the Sixth International Symposium on Melanoma and Other Cutaneous Malignancies on March 13- 14, 2009 in New York City
9. Photos: Children International Opens Center to Help Poor Children in India
10. Business Becomes Affiliate Member of International Trade Association
11. Olympus Acquires Holopack International Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: